Eterna Therapeutics Inc (ERNA) Stock Price

0.85 ▼ -0.07 (-7.61%)
Open: 0.92 Vol: 134.9K Day's range: 0.78 - 0.92 Feb 04, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ERNA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.81▲ 0.82▲ 0.82▲ 1.09▼ 1.16▼
MA10 0.81▲ 0.83▼ 0.86▼ 1.14▼ 1.22▼
MA20 0.84▼ 0.91▼ 1.00▼ 1.20▼ 1.31▼
MA50 0.96▼ 1.09▼ 1.11▼ 1.25▼ 2.04▼
MA100 1.09▼ 1.14▼ 1.18▼ 1.30▼ 11.10▼
MA200 1.14▼ 1.18▼ 1.22▼ 1.79▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.008▲ -0.002▼ -0.016▼ -0.029▼ 0.088▲
RSI 34.998▼ 22.810▼ 22.612▼ 29.765▼ 31.039▼
STOCH 47.582     7.933▼ 5.347▼ 46.083     24.222    
WILL %R -21.909▲ -71.502     -87.208▼ -86.000▼ -93.694▼
CCI 68.371     -65.985     -74.439     -318.028▼ -173.458▼
Latest Filters Detected On ERNA
▼ RSI $ERNA RSI(14) Crossed Below 30 Set Alert
▼ BREAK $ERNA Price Breaks 60 Days Low Set Alert
▼ BREAK $ERNA Price Breaks 30 Days Low Set Alert
▼ BREAK $ERNA Price Breaks 20 Days Low Set Alert
▼ BREAK $ERNA Price Breaks 10 Days Low Set Alert
Eterna Therapeutics Inc News
Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program
Wednesday, February 04, 2026 09:34 AM
Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced it has been selected as one of ...
Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA
Tuesday, February 03, 2026 06:06 AM
Access the “What This Means” segment here CAMBRIDGE, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the ...
Ernexa Therapeutics Announces Successful Pre-IND FDA Meeting and Continues Progress Toward First-in-Human Trial in Ovarian Cancer
Tuesday, January 06, 2026 12:15 AM
Regulatory alignment supports rapid progress, tech transfer already underway to accelerate clinical readiness Company on track to initiate first-in-human (FIH) trial for the treatment of ovarian ...
ERNA historical stock data
date open high low close volume
04/02/26 0.92 0.92 0.78 0.85 134,900
03/02/26 1.17 1.21 0.92 0.92 245,400
02/02/26 1.20 1.28 1.20 1.24 26,016
30/01/26 1.20 1.25 1.20 1.22 33,200
29/01/26 1.20 1.23 1.16 1.20 16,500
28/01/26 1.15 1.26 1.15 1.24 57,100
27/01/26 1.13 1.21 1.12 1.16 123,000
26/01/26 1.18 1.1925 1.14 1.17 51,929
23/01/26 1.20 1.22 1.16 1.20 25,200
22/01/26 1.18 1.26 1.14 1.24 64,400
Quote Details
52wk Low:0.78
52wk High:5.55
Vol:134.9K
Avg Vol(3m):2.6M
1Y Chng:-82.00%
1M Chng:-33.59%
Add to Watch List
More Information
Index US Composite
Market Cap. 7.22M